Investigación

Tratamiento del cáncer pediátrico

Buscador de publicaciones

Publicaciones

  • Paco-Mercader S, Casserras T, Rodríguez-García MA, Jou-Munoz C, Puigdelloses M, Ortez-Gonzalez CI, Diaz-Manera J, Gallardo E, Colomer J, Nascimento-Osorio A, Kalko SG and Jimenez-Mallebrera C.

    Transcriptome Analysis of Ullrich Congenital Muscular Dystrophy Fibroblasts Reveals a Disease Extracellular Matrix Signature and Key Molecular Regulators

    PLoS One . 10(12): . Nº de citas: 21

    [doi:10.1371/journal.pone.0145107]

  • Garzón M, García-Fructuoso G, Suñol M, Mora J and Cruz-Martínez O.

    Low-grade gliomas in children: single institutional experience in 198 cases

    CHILDS NERVOUS SYSTEM . 31(9): 1447-1459. Nº de citas: 8

    [doi:10.1007/s00381-015-2800-9]

  • Monterrubio C, Paco-Mercader S, Vilà-Ubach M, Rodriguez E, Glisoni R, Lavarino C, Schaiquevich P, Sosnik A, Mora J and Carcaboso AM.

    Combined Microdialysis-Tumor Homogenate Method for the Study of the Steady State Compartmental Distribution of a Hydrophobic Anticancer Drug in Patient-Derived Xenografts

    PHARMACEUTICAL RESEARCH . 32(9): 2889-2900. Nº de citas: 10

    [doi:10.1007/s11095-015-1671-9]

  • Ordóñez JL, Amaral AT, Carcaboso AM, Herrero-Martín D, Del Carmen García-Macías M, Sevillano V, Alonso D, Pascual-Pastó G, San-Segundo L, Vilà-Ubach M, Rodrigues T, Fraile S, Teodosio C, Mayo-Iscar A, Aracil M, Galmarini CM, Tirado OM, Mora J and de Álava E.

    The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin

    Oncotarget . 6(22): 18875-18890. Nº de citas: 64

    [doi:10.18632/oncotarget.4303]

  • Piquer-Gibert M, Alsina L, Giner MT, Cruz-Martínez O, Ruiz Echevarria K, Domínguez-Sánchez O, Plaza-Martín AM, Arostegui JI, de Valles G, Juan Otero M and Martín-Mateos MA.

    Non-Hodgkin lymphoma in pediatric patients with common variable immunodeficiency

    EUROPEAN JOURNAL OF PEDIATRICS . 174(8): 1069-1076. Nº de citas: 19

    [doi:10.1007/s00431-015-2508-6]

  • Morales-La Madrid A, Hashizume R and Kieran MW.

    Future Clinical Trials in DIPG: Bringing Epigenetics to the Clinic.

    Frontiers in oncology . 5: 148-148. Nº de citas: 40

    [doi:10.3389/fonc.2015.00148]

  • Mora J, Cruz-Martínez O, Lavarino C, Rios J, Vancells M, Parareda A, Salvador-Hernandez H, Suñol M, Carrasco-Torrents R, Guillen-Quesada A, Mañé S and de Torres C.

    Results of induction chemotherapy in children older than 18 months with stage-4 neuroblastoma treated with an adaptive-to-response modified N7 protocol (mN7)

    CLINICAL & TRANSLATIONAL ONCOLOGY . 17(7): 521-529. Nº de citas: 12

    [doi:10.1007/s12094-014-1273-8]

  • Cockle JV, Picton S, Levesley J, Ilett E, Carcaboso AM, Short S, Steel LP, Melcher A, Lawler SE and Brüning-Richardson A.

    Cell migration in paediatric glioma; characterisation and potential therapeutic targeting

    BRITISH JOURNAL OF CANCER . 112(4): 693-703. Nº de citas: 25

    [doi:10.1038/bjc.2015.16]

  • Juan-Ribelles A, Bautista F, Cañete A, Rubio-San-Simón A, Alonso-Saladrigues A, Hladun R, Rives-Solà S, Dapena JL, Fernández JM, Lassaletta Á, Cruz-Martínez O, Ramírez-Villar G, Fuster JL, de Heredia CD, García-Ariza M, Quiroga E, Del Mar Andrés M, Verdú-Amorós J, Molinés A, Herrero B, López M, Márquez C, Toboso M, Lendínez F, Sirvent JG, Tallón M, Rodríguez G, Acha T, Moreno L and Fernández-Teijeiro A.

    ECLIM-SEHOP: how to develop a platform to conduct academic trials for childhood cancer.

    CLINICAL & TRANSLATIONAL ONCOLOGY . : .

    [doi:10.1007/s12094-024-03445-0]